New Delhi: The Union Ministry of Health and Family Welfare has rejected the media report claiming that there will be a price hike in medicines. It said on Wednesday that media reports claiming a significant hike in medicine prices are “false, misleading and malicious.” For the unversed, some media reports had earlier claimed that medicine prices would spike by 12 per in April, which would affect more than 500 medicines.
However, the Union Ministry of Health and Family Welfare has now disclosed that the ceiling prices of scheduled medicines are annually revised by the National Pharmaceutical Pricing Authority (NPPA) based on the Wholesale Price Index (WPI).
“Based on the WPI increase of 0.00551 per cent, there will be no change in prevailing ceiling prices for 782 medicines, while 54 medicines will have a minuscule increase of Rs 0.01 (one paisa),” the ministry said.
The ceiling price of these 54 medicines ranges from Rs 90 to Rs 261. The WPI increase is the maximum increase permissible as per the provisions of Drug Price Control Orders (DPCO) 2013, and “manufacturers may or may not avail themselves of this minuscule increase in their medicines,” the ministry said.
“Thus, in the year FY 2024–25, there will be almost no change in the ceiling price of medicines based on WPI.”
The Ministry noted that depending upon the ceiling price of their medicines, the companies adjust their Maximum Retail Price (MRP) as MRP (excluding GST) can be any price that is less than the ceiling price.
It added that the revised prices “will be applicable from April 1,” and the details of the revised prices are available on NPPA’s website.
(With inputs from agencies)
For breaking news and live news updates, like us on Facebook or follow us on Twitter and Instagram. Read more on Latest Business News on India.com.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts Cookies Policy.